Electrophysiology Devices Market Research Report, Industry Analysis, Business Development, Size, Share, Trends,Growth, Forecast To 2026

The global electrophysiology devices market size is projected to reach USD 10.51 billion by 2026. According to a report published by Fortune Business Insights, titled “Electrophysiology Devices Market Size, Share & Industry Analysis, By Type (Ablation Catheters, Diagnostic Catheters, Mapping Systems, Accessories & Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT), Ventricular Tachycardia ,and Others),By End User (Hospitals & ASCs, and Specialty Clinics & Diagnostic Centres), and Regional Forecast, 2019-2026,” the market size was USD 4.60 billion in 2018 and is projected to exhibit a CAGR of 10.9% during the forecast period.

Electrophysiology devices are used in the treatment of severe cardiovascular diseases. The high prevalence of heart-related disorders has created massive product demand across the world. Increasing adoption of habits such as alcohol consumption and smoking will have a positive impact on market growth. The advent of technologically advanced electrophysiology devices has enabled enhanced operating efficiency in surgical procedures. Improving health reimbursement policies, coupled with the increasing investment in healthcare infrastructure will open up a huge potential for market growth. The growing prevalence of atrial fibrillation in several countries across the world has opened up a massive potential for market growth. Recent technological advancements have fuelled the demand for these devices.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this [Market].


For More Information :  https://www.fortunebusinessinsights.com/industry-reports/electrophysiology-devices-market-101730

Increasing Number of Product Launches to Aid Growth

The report provides an in-depth analysis of the influence of major factors on the market in recent years. Among all factors, the increasing number of product launches have made the highest impact on the growth of the market in recent years. The report highlights a few of the major products of recent years. In September 2019, Biosense Webster Inc., announced the launch of CARTONET. The device was the world’s first secure cloud-based network, aimed to review and analyze atrial fibrillation cases. The device successfully enhanced the overall efficiency of the procedure. Abbott’s new electrophysiology mapping catheter system was another product that has made a positive impact on the market in recent years.

Increasing Prevalence of Heart Failure to Aid Growth of the Market in North America

Among all regions, North America is projected to emerge dominant in the coming years. The increasing heart failure rates in several countries across this region, coupled with the increasing adoption of unhealthy lifestyle habits will aid growth of the market in this region. The market in Europe will witness significant growth, owing to the high prevalence of atrial fibrillation in countries such as Germany, Spain, and Italy will contribute to the growth of the market in Europe.

More Trending Topics from Fortune Business Insights :

Exocrine Pancreatic Insufficiency Therapeutics Market, , Share, Growth, Sales and Drivers Analysis Research Report 2026

Exocrine Pancreatic Insufficiency Therapeutics Market to reach USD 2.55 Billion by 2026; Rising Prevalence of Severe Chronic Disorders to Favour Growth: Fortune Business Insights

Comments are closed